Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears Meridian's C. difficile Test for Pediatric Patients

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today announced the US Food and Drug Administration has cleared its illumigene C. difficile test for pediatric use.

The test is based on Meridian's loop amplification technology, which is isothermal and requires no costly capital equipment, and targets the region of the C. difficile DNA present in all toxin A and/or toxin B producing strains.

The FDA originally gave Meridian's molecular amplification test 510(k) clearance in July.

According to Meridian, the FDA action announced today makes its test the only one cleared by the agency for use on children under the age of two.

"As we monitored the C. difficile market, we recognized and acted upon the increasing prevalence of pediatric C. difficile in order to be able to address the growing needs of our clinical lab customers," Jake Kraeutler, CEO of Meridian, said in a statement. "This new pediatric indicator for illumigene C. difficile will provide our customers with a critical loop to help detect and manage this devastating infection in young children."

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.